Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra Aubry

Showing results (61-70 of 99) with videos related to

Pageof 10
Sort By:
Microbial Biotechnology|September 11, 2024
Contribution of machine learning for subspecies identification from Mycobacterium abscessus with MALDI-TOF MS in solid and liquid mediaAlexandre Godmer, Lise Bigey, Quentin Giai-Gianetto, et al.
Antimicrobial Agents and Chemotherapy|October 4, 2006
Functional analysis of DNA gyrase mutant enzymes carrying mutations at position 88 in the A subunit found in clinical strains of Mycobacterium tuberculosis resistant to fluoroquinolonesStéphanie Matrat, Nicolas Veziris, Claudine Mayer, et al.
The European Respiratory Journal|May 21, 2020
Fully weekly antituberculosis regimen: a proof-of-concept studyFatma Kort, Laure Fournier Le Ray, Aurélie Chauffour, et al.
The Journal of Antimicrobial Chemotherapy|January 27, 2012
A systematic review of gyrase mutations associated with fluoroquinolone-resistant Mycobacterium tuberculosis and a proposed gyrase numbering systemFernanda Maruri, Timothy R Sterling, Anne W Kaiga, et al.
European Journal of Medicinal Chemistry|September 27, 2006
Design, synthesis and activity against Toxoplasma gondii, Plasmodium spp., and Mycobacterium tuberculosis of new 6-fluoroquinolonesGuillaume Anquetin, Jacques Greiner, Nassira Mahmoudi, et al.
The Journal of Antimicrobial Chemotherapy|May 24, 2017
Are moxifloxacin and levofloxacin equally effective to treat XDR tuberculosis?Thomas Maitre, Grégoire Petitjean, Aurélie Chauffour, et al.
Emerging Infectious Diseases|July 17, 2019
Erwinia billingiae as Unusual Cause of Septic Arthritis, France, 2017Isabelle Bonnet, Baptiste Bozzi, Eric Fourniols, et al.
Journal of Medical Microbiology|August 4, 2017
Extra-corporeal membrane oxygenation-associated infections: implication of extra-intestinal pathogenic Escherichia coli clonesJonathan Messika, Olivier Clermont, Luce Landraud, et al.
Bioorganic & Medicinal Chemistry Letters|November 14, 2021
Lipophilic quinolone derivatives: Synthesis and in vitro antibacterial evaluationElodie Sadowski, Beatrice Bercot, Aurélie Chauffour, et al.
Microorganisms|July 27, 2022
How a PCR Sequencing Strategy Can Bring New Data to Improve the Diagnosis of Ethionamide ResistanceThomas Maitre, Florence Morel, Florence Brossier, et al.
Pageof 10

Showing results (61-70 of 99) with videos related to

Sort By:
Pageof 10
Microbial Biotechnology|September 11, 2024
Contribution of machine learning for subspecies identification from Mycobacterium abscessus with MALDI-TOF MS in solid and liquid mediaAlexandre Godmer, Lise Bigey, Quentin Giai-Gianetto, et al.
Antimicrobial Agents and Chemotherapy|October 4, 2006
Functional analysis of DNA gyrase mutant enzymes carrying mutations at position 88 in the A subunit found in clinical strains of Mycobacterium tuberculosis resistant to fluoroquinolonesStéphanie Matrat, Nicolas Veziris, Claudine Mayer, et al.
The European Respiratory Journal|May 21, 2020
Fully weekly antituberculosis regimen: a proof-of-concept studyFatma Kort, Laure Fournier Le Ray, Aurélie Chauffour, et al.
The Journal of Antimicrobial Chemotherapy|January 27, 2012
A systematic review of gyrase mutations associated with fluoroquinolone-resistant Mycobacterium tuberculosis and a proposed gyrase numbering systemFernanda Maruri, Timothy R Sterling, Anne W Kaiga, et al.
European Journal of Medicinal Chemistry|September 27, 2006
Design, synthesis and activity against Toxoplasma gondii, Plasmodium spp., and Mycobacterium tuberculosis of new 6-fluoroquinolonesGuillaume Anquetin, Jacques Greiner, Nassira Mahmoudi, et al.
The Journal of Antimicrobial Chemotherapy|May 24, 2017
Are moxifloxacin and levofloxacin equally effective to treat XDR tuberculosis?Thomas Maitre, Grégoire Petitjean, Aurélie Chauffour, et al.
Emerging Infectious Diseases|July 17, 2019
Erwinia billingiae as Unusual Cause of Septic Arthritis, France, 2017Isabelle Bonnet, Baptiste Bozzi, Eric Fourniols, et al.
Journal of Medical Microbiology|August 4, 2017
Extra-corporeal membrane oxygenation-associated infections: implication of extra-intestinal pathogenic Escherichia coli clonesJonathan Messika, Olivier Clermont, Luce Landraud, et al.
Bioorganic & Medicinal Chemistry Letters|November 14, 2021
Lipophilic quinolone derivatives: Synthesis and in vitro antibacterial evaluationElodie Sadowski, Beatrice Bercot, Aurélie Chauffour, et al.
Microorganisms|July 27, 2022
How a PCR Sequencing Strategy Can Bring New Data to Improve the Diagnosis of Ethionamide ResistanceThomas Maitre, Florence Morel, Florence Brossier, et al.
Pageof 10